Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma

NCT03033576 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

94

Enrollment

NIH

Sponsor class

Conditions

Clinical Stage III Cutaneous Melanoma AJCC v8
Clinical Stage IV Cutaneous Melanoma AJCC v8
Melanoma of Unknown Primary
Mucosal Melanoma
Unresectable Cutaneous Melanoma
Unresectable Melanoma

Interventions

BIOLOGICAL: Ipilimumab
BIOLOGICAL: Nivolumab

Sponsor

National Cancer Institute (NCI)